Imane Nafia, Chief Scientific Officer at Explicyte, will attend the 39th Annual Meeting of the Society for Immunotherapy of Cancer – SITC, (Houston USA, November 6-10, 2024), to share some new developments and translational research work (abstracts submitted).
![SITC 2024](https://explicyte.com/wp-content/uploads/2024/06/SITC.jpg)